Epidemiological update: A(H7N9) influenza virus, China, 19 December 2013
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) avian influenza virus in patients in eastern China.
Epidemiological update A(H7N9) influenza, 6 February 2014
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China. Since then, human cases have continued to be reported, and as of 7 February 2014 (Figure 1), there have been 308 laboratory-confirmed cases: Zhejiang (122), Guangdong (54), Shanghai (42), Jiangsu (36), Fujian (19), Hunan (7), Jiangxi (5), Henan (4), Anhui (4) ,Beijing (3), Shandong (2), Hebei (1), Guangxi (2), Guizhou (1), Hong Kong (4) and Taiwan (2). In addition, the virus has been detected in one asymptomatic case in Beijing.
Very low public health threat related to outbreak of avian influenza A(H5N8) in turkeys in Germany
The risk of transmission of avian influenza A(H5N8) to the general public in the EU/EEA countries is extremely low.
Recent upsurge of A(H7N9) cases in China, updated rapid risk assessment
A steep increase of human cases of avian influenza A(H7N9) has been reported since the beginning of December 2016 from China. At present, the most immediate threat to EU citizens is to those living or visiting influenza A(H7N9)-affected areas in China concludes the updated rapid risk assessment.
Annual epidemiological report 2011 [2009 data]
Reporting on 2009 surveillance data and 2010 epidemic intelligence data
- antibiotic resistance
- avian influenza virus
- food- and waterborne diseases
- healthcare-associated infections
- HIV infection
- influenza in humans, avian origin
- influenza in humans, seasonal
- respiratory diseases
- sexually transmitted infections
- vaccine preventable diseases
- viral hepatitis
Influenza and other Respiratory Viruses Programme
The Programme aims to support European bodies and Member States in the enactment of European Council Recommendations and Communications on seasonal influenza immunisation and pandemic preparedness.
European Reference Laboratory Network for Human Influenza (ERLI-Net)
The ERLI-Net sub-network of reference laboratories of the European Influenza Surveillance Network carries out virological surveillance of human influenza in the EU/EEA through the EISN timely reporting mechanism and strengthening laboratory capacity for influenza virus detection, antiviral susceptibility testing and typing.
About the network
The main objectives of ERLI-Net are to carry out virological surveillance of human influenza and to ensure that data are shared through the European Influenza Surveillance Network (EISN) reporting mechanisms in a timely manner.
Influenza laboratory quality control
In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.